Triple

T15983591
Position Surface form Disambiguated ID Type / Status
Subject European Pharmacopoeia E387634 entity
Predicate hasDecisionMakingBody P9960 FINISHED
Object European Pharmacopoeia Commission E387634 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Pharmacopoeia Commission | Statement: [European Pharmacopoeia, hasDecisionMakingBody, European Pharmacopoeia Commission]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: European Pharmacopoeia Commission
Context triple: [European Pharmacopoeia, hasDecisionMakingBody, European Pharmacopoeia Commission]
  • A. European Pharmacopoeia chosen
    The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
  • B. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • C. European Union Drugs Agency
    The European Union Drugs Agency is the EU’s central body responsible for providing scientific analysis, monitoring, and policy support on drugs and drug addiction across member states.
  • D. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • E. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d86da94ccc819083d187f5dc6a123e completed April 10, 2026, 3:25 a.m.
NER Named-entity recognition batch_69e15756d6488190ac35da00e96ce21d completed April 16, 2026, 9:40 p.m.
NED1 Entity disambiguation (via context triple) batch_69ffdbc8a8a081908ac1b431f524d650 completed May 10, 2026, 1:13 a.m.
Created at: April 10, 2026, 4:54 a.m.